论文部分内容阅读
目的:探讨依达拉奉联合血栓通注射液治疗急性脑梗死的临床疗效。方法:将134例确诊急性脑梗死患者随机分为对照组67例和观察组67例,两组患者均给予脱水、降颅压、抗凝、营养支持及相应的对症治疗,在此基础上对照组给予血栓通注射液10mL加入0.9%氯化钠注射液250mL静脉滴注,1次/d,观察组采用依达拉奉30mg加入生理盐水100mL中静脉滴注,2次/d,血栓通注射液10mL加入0.9%氯化钠注射液250mL静脉滴注,1次/d,两组患者均14d为1个疗程。对比观察两组患者的临床疗效。结果:观察组总有效率为92.5%,对照组总有效率为76.1%,观察组总有效率显著高于对照组总有效率,两组差异显著(P<0.05)。结论:依达拉奉联合血栓通注射液治疗急性脑梗死可产生协同互补作用,可显著提高临床疗效,且安全可靠,值得临床推广。
Objective: To investigate the clinical efficacy of edaravone combined with Xueshuantong injection in the treatment of acute cerebral infarction. Methods: A total of 134 patients with acute cerebral infarction were randomly divided into control group (67 cases) and observation group (67 cases). Both groups were given dehydration, intracranial pressure reduction, anticoagulation, nutritional support and corresponding symptomatic treatment. On this basis, Group given Xueshuantong injection 10mL 0.9% sodium chloride injection 250mL intravenous infusion, 1 / d, the observation group with edaravone 30mg added saline 100mL intravenous infusion, 2 times / d, thrombosis injection Liquid 10mL added 0.9% sodium chloride injection 250mL intravenous infusion, 1 / d, two groups of patients were 14d for a course of treatment. Compare the clinical efficacy of two groups of patients. Results: The total effective rate was 92.5% in the observation group and 76.1% in the control group. The total effective rate in the observation group was significantly higher than that in the control group (P <0.05). Conclusion: Edaravone combined with Xueshuantong Injection in the treatment of acute cerebral infarction can produce synergistic and complementary effects, which can significantly improve the clinical efficacy, and is safe and reliable, which is worthy of clinical promotion.